Background {#Sec1}
==========

One-lung ventilation, used to isolate and protect the lung, has been widely used in thoracic surgery. Nonphysiologic tidal volumes, loss of normal functional residual capacity and hyperperfusion in the ventilated lung during one-lung ventilation result in alveolar damage and inflammation response in the lung. These changes make patients susceptible to PPCs (Lohser and Slinger [@CR14]). Various ventilation strategies, such as pressure-controlled ventilation (PCV), volume-controlled ventilation (VCV), conventional ventilation (CV) and protective ventilation (PV), are used in one-lung ventilation. The ideal ventilation strategy should minimize the risk of PPCs while also benefitting both gas exchange and pulmonary mechanics.

High tidal volume (*V*~T~) is associated with increased areas of overinflation but decreased areas of atelectasis at end-inspiration (Guldner et al. [@CR6]). Protective ventilation with low *V*~T~ is thought to result in less ventilator-induced lung injury and has become a routine strategy in patients with ARDS (Petrucci and De Feo [@CR23]). Recent studies have reported similar results in that low *V*~T~ prevents postoperative complications in surgical patients (Serpa Neto et al. [@CR29], [@CR30]). However, the effect of low *V*~T~ on patients undergoing one-lung ventilation remains unclear. In some studies, PV has been associated with a decreased oxygenation index and more dead space ventilation without decreases in the incidence of PPCs (Maslow et al. [@CR16]; Jung et al. [@CR10]; Blank et al. [@CR2]; Neto et al. [@CR21]). In other studies, PV was associated with a lower incidence of PPCs and satisfactory gas exchange (Schilling et al. [@CR28]; Yang et al. [@CR37]; Serpa Neto et al. [@CR29], [@CR30]). VCV and PCV are also used in one-lung ventilation. PCV may result in lower airway pressure and a more homogeneous distribution of the tidal volume; PCV also has less of an effect on cardiac function than VCV (Al Shehri et al. [@CR1]). However, tidal volumes in PCV are highly variable (Della Rocca and Coccia [@CR5]). The benefits of PCV in terms of oxygenation and protection against lung damage should be balanced.

This meta-analysis aims to investigate the association between ventilation strategies and PPCs; the length of hospital stay, intraoperative P~plateau~, PaO~2~/FiO~2~ and MAP were compared as the secondary outcomes. We hypothesize that PV with low *V*~T~ and PCV have protective effects on PPCs in one-lung ventilation.

Methods {#Sec2}
=======

We used the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) recommended by the PRISMA working group (<http://www.prisma-statement.org/>) in this meta-analysis (Moher et al. [@CR18]). This meta-analysis was registered on PROSPERO (Prospective Register of Ongoing Systematic Reviews, <http://www.crd.york.ac.uk/prospero>, Registration No. CRD42015022087).

Eligibility criteria {#Sec3}
--------------------

We compared 2 types of interventions with 2 control groups. In the comparison of PCV and VCV, the intervention group was the PCV group and the control group was the VCV group. PCV was defined as ventilation under pressure control with or without PEEP in one-lung ventilation. VCV was defined as ventilation under volume control with or without PEEP in one-lung ventilation. In the comparison of PV and CV, the intervention group was the PV group and the control group was the CV group. According to previous studies, PV was defined as ventilation using low *V*~T~ (*V*~T~ ≤ 6 ml/kg predicted body weight) with or without PEEP and with or without alveolar recruitment strategies in one-lung ventilation. CV was defined as ventilation using *V*~T~ ≥ 7 ml/kg predicted body weight with or without PEEP and without recruitment maneuvers in one-lung ventilation (Lohser [@CR13]; Della Rocca and Coccia [@CR5]).

The included studies met the following criteria: randomized controlled trials of patients aged 18 years or older who were undergoing one-lung ventilation during a surgical procedure. Randomized clinical trials (RCTs) were excluded if they did not involve a surgical procedure, if they included patients undergoing cardiac surgery, if they included patients with cardiac diseases, sepsis or ARDS before surgery, if they were conference abstracts or if full-text articles could not be obtained, if they did not focus on the comparisons of different ventilation strategies in the dependent lung, if the intervention group and control group had different ventilation settings during two-lung ventilation (TLV), or if the RCTs did not report any outcomes mentioned above. Animal studies were also excluded.

The primary outcome of interest was the development of PPCs during follow up, defined as the development of atelectasis, lung infiltration, pneumonia or ARDS. The secondary outcomes included the length of hospital stay, intraoperative P~plateau~, PaO~2~/FiO~2~ and MAP. PaO~2~/FiO~2~ at 20--40 min in one-lung ventilation in randomized parallel studies was included in the analysis of PaO~2~/FiO~2~. Cross-over studies were not used to evaluate the effect of ventilation strategies on PPCs, the length of hospital stay or PaO~2~/FiO~2~.

Information sources {#Sec4}
-------------------

We performed a literature search in PubMed, EMBASE, the Cochrane Library, and Ovid MEDLINE in May 2015. The last search was performed on May 14th, 2015.

Search strategy {#Sec5}
---------------

The terms 'anesthesia', 'anaesthesia', 'surgery', 'surgical', 'operative', 'surgical operations', 'intra-operative care', 'postoperative care', 'preoperative care', 'perioperative care', 'one lung ventilation', 'single-lung ventilation', 'single-lung ventilations', 'lung separation techniques', 'lung separation technique' were used in various combinations. The search was limited to clinical trials. The detailed search strategy is provided as Additional file [1](#MOESM1){ref-type="media"}.

Study selection {#Sec6}
---------------

Two reviewers (ZL, XWL) conducted the systematic search and independently reviewed the titles and abstracts of the studies. Only reports meeting the criteria listed above were included for data extraction, trial quality assessment and the analysis of results. Any disagreements among reviewers was resolved by discussion with a third author (JZ).

Data collection process {#Sec7}
-----------------------

Data were extracted independently by two reviewing authors (ZL, XWL). Authors of the original studies were contacted to provide additional information if necessary.

Data items {#Sec8}
----------

The following information was extracted: study design (randomized parallel studies, randomized cross-over studies), number of patients, ventilation strategies, type of surgery, duration of one-lung ventilation, outcomes and preoperative FEV1 (% of predicted).

Risk of bias {#Sec9}
------------

The Cochrane tool for risk of bias was used to assess the risk of bias for all studies (Higgins et al. [@CR8]). The risk of bias for random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and others was evaluated and classified as "low", "high", or "unclear" risk. We used funnel plots to assess reporting bias, and these plots are available in the Additional file [1](#MOESM1){ref-type="media"}. The risk of bias evaluation was conducted independently by two authors (ZL, XWL).

Synthesis of results {#Sec10}
--------------------

Review-Manager software (RevMan, version 5.3; The Cochrane Collaboration, Oxford, UK) was used to conduct the data analysis. For binary outcomes, PPCs were summarized using odds ratios and their 95 % confidence intervals (CIs). Mean difference and 95 % CI were reported for continuous outcomes. We used I^2^ to estimate heterogeneity within the studies (Higgins et al. [@CR7]). A fixed-effect model was used to analyze the data. If I^2^ was greater than 50 %, we utilized the random-effects model.

Additional analysis {#Sec11}
-------------------

When comparing the clinical effect of PCV with VCV, we performed subgroup analyses to determine if outcomes could be influenced by the setting of *V*~T~ or the type of PCV. The setting of *V*~T~ was divided into *V*~T~ ≤ 6 ml/kg and *V*~T~ ≥ 7 ml/kg predicted body weight. The type of PCV was divided into conventional pressure-controlled ventilation and PCV-VG. Subgroup analysis was performed only when there were no less than 3 studies providing information for one outcome. If I^2^ \> 50 %, we performed a sensitivity analysis by removing trials and reanalyzing the remaining studies.

Quality assessment {#Sec12}
------------------

A Measure Tool to Assess Systematic Reviews (AMSTAR) was applied to assess the methodological quality. Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the evidence quality.

Results {#Sec13}
=======

Study selection {#Sec14}
---------------

A total of 467 studies were screened and assessed for eligibility. Of these, 446 records were excluded for a variety of reasons as shown in Fig. [1](#Fig1){ref-type="fig"}. The remaining 21 randomized controlled trials (reporting on 22 comparisons) involving 1083 one-lung ventilation patients undergoing non-cardiac surgery were included in this meta-analysis. Eleven studies including 436 patients compared PCV with VCV, and 11 studies including 657 patients compared PV with CV. Data shown in the histogram were collected by contacting the corresponding authors by e-mail for one trial (Jung et al. [@CR10]).Fig. 1Study flow diagram

Study characteristics {#Sec15}
---------------------

Eleven of the 21 studies included in this meta-analysis were randomized parallel studies and 10 studies were randomized cross-over studies. The study sample sizes ranged from 18 to 120 patients. The trials involved both open thoracic surgery and video-assisted thoracic surgery. The duration of one-lung ventilation ranged from 73.4 to 109 min. The characteristics and risk of bias in each study are shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, respectively.Table 1Characteristics of included studiesAuthorYearNo. of patientsStudy interventionDetails of *V* ~T~ (ml/kg) and PEEP (cmH~2~O)Age (year), mean (SD)Type of surgeryDuration of one-lung ventilation in each mode (min), mean (SD)OutcomesTime point of measurement of outcomesPreoperative FEV1 (% of predicted) (SD)*Randomized parallel study*Hu et al.[@CR9](1) 15\
(2) 15(1) PCV-VG\
(2) VCV(1) *V* ~T~ = 7 PEEP = 0\
(2) *V* ~T~ = 7 PEEP = 0(1) 61 (6)\
(2) 62 (7)VATS(1) 147(22)\
(2) 154(52)Respiratory parameters, gas exchange, hemodynamics15 and 60 min after OLVNot reportedQutubet al.[@CR26](1) 13\
(2) 13\
(3) 13(1) PV 4\
(2) PV 6\
(3) CV(1) *V* ~T~ = 4 PEEP = 5\
(2) *V* ~T~ = 6 PEEP = 5\
(3) *V* ~T~ = 8 PEEP = 5(1) 42 (32--54)\
(2) 39.5 (31--51)\
(3) 36 (29--48)VATSNot reportedExtravascular lung water content index, respiratory parameters, gas exchange, clinical outcomes15, 45 min after OLV; 48 h, 30d post operation(1) 87.1 (3.0)\
(2) 88.4 (2.9)\
(3) 85.8 (4.1)Jung et al.[@CR10](1) 30\
(2) 30(1) PV\
(2) CV(1) *V* ~T~ = 6 PEEP = 8\
(2) *V* ~T~ = 10 PEEP = 0(1) 35.2 (10.2)\
(2) 36.3 (9.5)VATSNot reportedRespiratory parameters5, 15, 30, 45 min after OLVNot reportedShen et al.[@CR31](1) 53\
(2) 48(1) PV\
(2) CV(1) *V* ~T~ = 5 PEEP = 5\
(2) *V* ~T~ = 8 PEEP = 0(1) 60.5 (7.3)\
(2) 57.2 (9.1)MIE(1) 72.2 (23.6)\
(2) 75.0 (18.8)Clinical outcomes, gas exchange, cytokines expression18 h post operation, 30d post operation(1) 92.8 (14.6)\
(2) 87.1 (16.9)Maslow et al.[@CR16](1) 16\
(2) 16(1) PV\
(2) CV(1) *V* ~T~ = 5 PEEP = 5\
(2) *V* ~T~ = 10 PEEP = 0(1) 62 (14.4)\
(2) 69.6 (12.9)Thoracic surgery(1) 42 (8.3)\
(2) 46 (9.5)Respiratory parameters, gas exchange, hemodynamics, clinical outcomes5, 10, 15, 20, 30 min after OLV(1) 85.8 (21.7)\
(2) 75.4 (16.4)Ye and Li[@CR38](1) 10\
(2) 10\
(3) 10(1) PCV\
(2) VCV\
(3) PV(1) *V* ~T~ = 8 PEEP = 0\
(2) *V* ~T~ = 8 PEEP = 0\
(3) *V* ~T~ = 6 PEEP = 520--65Thoracic surgeryNot reportedRespiratory parameters, gas exchange20, 45 and 70 min after OLVNot reportedYang et al.[@CR37](1) 50\
(2) 50(1) PV\
(2) CV(1) *V* ~T~ = 6 PEEP = 5\
(2) *V* ~T~ = 10 PEEP = 0(1) 58 (12)\
(2) 60 (10)Thoracic surgery(1) 120 (41)\
(2) 126 (53)Clinical outcomes, gas exchange, hemodynamics15, 60 min after OLV; 2, 72 h post operation(1) 105 (9)\
(2) 104 (17)Boules and Ghobrial[@CR3](1) 18\
(2) 19(1) PCV-VG\
(2) VCV(1) *V* ~T~ = 6 PEEP = 0\
(2) *V* ~T~ = 6 PEEP = 0(1) 33.4 (6.4)\
(2) 34.7 (7.6)Thoracic surgery(1) 88.7 (42.1)\
(2) 75.6 (34.7)Respiratory parameters, gas exchange, hemodynamics, clinical outcomes30 min after OLV;72 h post operation(1) 73.4 (11.7)\
(2) 74.3 (12.5)Pardos et al.[@CR22](1) 55\
(2) 55(1) PCV +PEEP\
(2) VCV + PEEP(1) *V* ~T~ = 8 PEEP = 0; 20 min after OLV PEEP = 5\
(2) *V* ~T~ = 8 PEEP = 0; 20 min after OLV PEEP = 5(1) 59.5 (13)\
(2) 63.9 (11)Thoracic surgeryNot reportedRespiratory parameters, gas exchange, clinical outcomes20, 30 and 40 min after OLV; 24 h post operation; 30d post operation(1) 91.2 (24)\
(2) 87.9 (21)Lin et al.[@CR12](1) 20\
(2) 20(1) PV\
(2) CV(1) *V* ~T~ = 5--6 PEEP = 3--5\
(2) *V* ~T~ = 10 PEEP unclear(1) 55\
(2) 54Thoracic surgeryNot reportedCytokines expression, respiratory parameters, gas exchange120 min after OLV, 24 h post operationNot reportedMichelet et al.[@CR17](1) 26\
(2) 26(1) PV\
(2) CV(1) *V* ~T~ = 5 PEEP = 5\
(2) *V* ~T~ = 9 PEEP = 0(1) 61 (10)\
(2) 60 (8.5)Thoracic surgery(1) 85 (29)\
(2) 89 (29)Cytokines expression, respiratory parameters, gas exchange, clinical outcomes15 min after OLV; at the end of OLV; 1,18 h post operation(1) 93 (19)\
(2) 96 (18)*Randomized cross*-*over study*Song et al.[@CR32]27(1) PCV-VG\
(2) VCV(1) *V* ~T~ = 8 PEEP = 0\
(2) *V* ~T~ = 8 PEEP = 063.6 (9.7)Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange, hemodynamics30 min after OLV in each mode107.3 (33.1)Pu et al.[@CR25]20(1) PCV-VG\
(2) VCV(1) *V* ~T~ = 8--10 PEEP unclear\
(2) *V* ~T~ = 8--10 PEEP unclear59.8 (unclear)Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange, hemodynamics30 min after OLV in each modeNot reportedAl Shehri et al.[@CR1]28(1) PCV\
(2)VCV(1) *V* ~T~ = 6 PEEP = 5\
(2) *V* ~T~ = 6 PEEP = 5(1) 37.4 (11.51)\
(2) 39.1 (13.93)Thoracic surgery(1) 30\
(2) 30Right ventricular function, gas exchange, hemodynamics30 min after OLV in each mode84.5 (10.8)Végh et al.[@CR36]100(1) PV\
(2) CV(1) *V* ~T~ = 5 PEEP = 5\
(2) *V* ~T~ = 10 PEEP = 0(1) 64 (12)\
(2) 63 (12)Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange, hemodynamics30 min after OLV in each mode91.5\
(14.0)Roze et al.[@CR27]82(1) PV\
(2) CV(1) *V* ~T~ = 5 PEEP = 9 (1)\
(2) *V* ~T~ = 8 PEEP = 5(1) 62 (10)\
(2) 60 (10)Thoracic surgery(1) 10\
(2) 10Respiratory parameters, Gas exchange, hemodynamics10 min after OLV in each modeNot reportedSungur Ulke et al.[@CR33]31(1) PV\
(2) CV(1) *V* ~T~ = 6\
PEEP = 5\
(2) *V* ~T~ = 8 PEEP = 058.3 (7.2)Thoracic surgery(1) 20\
(2) 20Respiratory parameters, gas exchange, hemodynamics20 min after OLV in each mode75 (14.7)Montes et al.[@CR19]41(1) PCV\
(2)VCV(1) *V* ~T~ = 6 PEEP = 5\
(2) *V* ~T~ = 6 PEEP = 5(1) 59.1 (16)\
(2) 56.1 (17)Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange30 min after OLV in each mode91.2 (19.3)Choi et al.[@CR4]18(1) PCV\
(2) VCV(1) *V* ~T~ = 8 PEEP = 0\
(2) *V* ~T~ = 9 PEEP = 061.4 (10.3)Robot-assisted esophagectomy(1) 30\
(2) 30Respiratory parameters, gas exchange, hemodynamics30 min after OLV in each mode109.1 (21.2)Unzueta et al.[@CR35]57(1) PCV\
(2) VCV(1) *V* ~T~ = 9 PEEP = 0\
(2) *V* ~T~ = 9 PEEP = 0(1) 58.25 (15.15) (2) 54.75 (13.91)Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange30 min after OLV in each mode82.2 (17.5)Tugrul et al.[@CR34]48(1) PCV\
(2) VCV(1) *V* ~T~ = 10 PEEP unclear\
(2) *V* ~T~ = 10 PEEP unclear56.4Thoracic surgery(1) 30\
(2) 30Respiratory parameters, gas exchange, hemodynamics30 min after OLV in each mode76.8 (14)*ARS* alveolar recruitment strategy, *CV* conventional ventilation, *MIE* minimally invasive esophagectomy, *PCV* pressure-controlled ventilation, *PCV*-*VG* volume guaranteed pressure-controlled ventilation, *PV* protective ventilation, *VATS* video-assisted thoracoscopic surgery, *VCV* volume-controlled ventilationTable 2Risk of bias in included studiesAuthorYearRandom sequence generationAllocation concealmentBlinding of participants and personnelBlinding of outcome assessmentIncomplete outcome dataSelective reportingOther bias*Randomized parallel study*Hu et al.[@CR9]LowHighLowLowUnclearUnclearLowQutub et al.[@CR26]UnclearUnclearLowLowLowLowLowJung et al.[@CR10]LowHighLowLowUnclearUnclearLowShen et al.[@CR31]LowUnclearLowUnclearLowHighLowMaslow et al.[@CR16]UnclearUnclearLowUnclearLowUnclearLowYang et al.[@CR37]LowLowLowLowLowUnclearLowYe and Li[@CR38]UnclearUnclearLowLowUnclearUnclearLowBoules and Ghobrial[@CR3]LowUnclearLowUnclearUnclearUnclearLowPardos et al.[@CR22]UnclearHighLowUnclearUnclearUnclearLowLin et al.[@CR12]UnclearUnclearLowLowUnclearUnclearLowMichelet et al.[@CR17]LowLowLowUnclearLowUnclearHigh*Randomized cross*-*over study*Song et al.[@CR32]LowUnclearLowLowUnclearUnclearLowPu et al.[@CR25]UnclearUnclearLowLowUnclearUnclearLowAl Shehri et al.[@CR1]LowLowLowLowUnclearLowHighVégh et al.[@CR36]LowUnclearLowLowUnclearLowLowRoze et al.[@CR27]LowUnclearLowLowLowLowLowSungur Ulke et al.[@CR33]LowUnclearLowLowUnclearUnclearLowMontes et al.[@CR19]LowUnclearLowLowLowUnclearLowChoi et al.[@CR4]LowUnclearLowLowLowUnclearLowUnzueta et al.[@CR35]LowUnclearLowLowLowUnclearLowTugrul et al.[@CR34]UnclearUnclearLowLowUnclearUnclearLow

Results of individual studies and synthesis of results {#Sec16}
------------------------------------------------------

### Postoperative pulmonary complications {#Sec17}

Two of the 11 studies including 147 patients comparing PCV with VCV reported PPCs as an outcome (Pardos et al. [@CR22]; Boules and Ghobrial [@CR3]). Both studies found that PCV did not have any advantages over VCV in terms of decreased incidence of PPCs (OR 1.05; 95 % CI 0.25--4.34; I^2^ = 0; P = 0.95) (Fig. [2](#Fig2){ref-type="fig"}a).Fig. 2Effect of ventilation strategies on postoperative pulmonary complications. **a** PCV versus VCV; **b** PV versus CV

Four of the 12 studies including 285 patients comparing PV with CV reported PPCs as an outcome (Michelet et al. [@CR17]; Yang et al. [@CR37]; Maslow et al. [@CR16]; Shen et al. [@CR31]). PV showed a protective effect over CV on respiratory complications after one-lung ventilation (OR 0.29; 95 % CI 0.15--0.57; I^2^ = 0; P \< 0.01) (Fig. [2](#Fig2){ref-type="fig"}b).

### Length of hospital stay {#Sec18}

Four studies including 272 patients comparing PV with CV reported the length of hospital stay as an outcome (Yang et al. [@CR37]; Maslow et al. [@CR16]; Shen et al. [@CR31]; Qutub et al. [@CR26]). No advantages in terms of the length of hospital stay were found in the PV group (MD −0.65; 95 % CI −1.59 to 0.30; I^2^ = 27 %; P = 0.18) (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Effect of ventilation strategies on length of hospital stay (days)

### Plateau airway pressure {#Sec19}

Eight of the 11 studies including 359 patients comparing PCV with VCV reported P~plateau~ as an outcome (Tugrul et al. [@CR34]; Unzueta et al. [@CR35]; Choi et al. [@CR4]; Pardos et al. [@CR22]; Montes et al. [@CR19]; Boules and Ghobrial [@CR3]; Al Shehri et al. [@CR1]; Pu et al. [@CR25]). PCV showed decreased P~plateau~ compared to VCV (MD −1.46; 95 % CI −2.58 to −0.34; I^2^ = 72 %; P = 0.01) (Fig. [4](#Fig4){ref-type="fig"}a).Fig. 4Effect of ventilation strategies on plateau airway pressure. **a** PCV versus VCV; **b** PV versus CV

Eight of the 12 studies including 497 patients comparing PV with CV reported P~plateau~ as an outcome (Michelet et al. [@CR17]; Lin et al. [@CR12]; Sungur Ulke et al. [@CR33]; Yang et al. [@CR37]; Roze et al. [@CR27]; Maslow et al. [@CR16]; Végh et al. [@CR36]; Jung et al. [@CR10]). PV decreased P~plateau~ compared to CV (MD −3.57; 95 % CI −5.74 to −1.76; I^2^ = 94 %; P \< 0.01) (Fig. [4](#Fig4){ref-type="fig"}b).

### PaO~2~/FiO~2~ {#Sec20}

Three randomized parallel trials including 167 patients comparing PCV and VCV reported PaO~2~/FiO~2~ at 20--30 min after OLV as an outcome (Pardos et al. [@CR22]; Boules and Ghobrial [@CR3]; Ye and Li [@CR38]). No differences in PaO~2~/FiO~2~ were found in those 2 groups (MD 47.56; 95 % CI −7.67 to 102.79; I^2^ = 91 %; P = 0.09) (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Effect of ventilation strategies on PaO~2~/FiO~2~

### Mean arterial pressure {#Sec21}

Six of the 11 studies including 181 patients comparing PCV and VCV reported MAP as an outcome (Tugrul et al. [@CR34]; Choi et al. [@CR4]; Boules and Ghobrial [@CR3]; Al Shehri et al. [@CR1]; Hu et al. [@CR9]; Pu et al. [@CR25]). No differences in MAP were found in those 2 groups (MD 0.26; 95 % CI −2.28--2.79; I^2^ = 0; P = 0.84) (Fig. [6](#Fig6){ref-type="fig"}a).Fig. 6Effect of ventilation strategies on mean arterial pressure. **a** PCV versus VCV; **b** PV versus CV

Four of the 12 studies including 222 patients comparing PV and CV reported MAP as an outcome (Michelet et al. [@CR17]; Sungur Ulke et al. [@CR33]; Végh et al. [@CR36]; Qutub et al. [@CR26]). No differences in MAP were found in those 2 groups (MD −0.89; 95 % CI −3.20 to 1.41; I^2^ = 0; P = 0.45) (Fig. [6](#Fig6){ref-type="fig"}b).

### Subgroup analysis {#Sec22}

Subgroup analysis regarding the volume of *V*~T~ showed a decrease in P~plateau~ (MD −2.58; 95 % CI −4.74 to −0.43; I^2^ = 85 %; P = 0.02) in patients undergoing PCV with *V*~T~ 6 ml/kg predicted body weight compared to VCV. In the groups with *V*~T~ ≥ 7 ml/kg, no significant benefit was found in patients undergoing PCV compared to VCV (MD −0.58; 95 % CI −1.37--0.20) (Table [3](#Tab3){ref-type="table"}).Table 3Subgroup analyses of patients undergoing one-lung ventilation with PCV and VCVVolume of *V* ~T~Type of PCV≤6 ml/kg≥7 ml/kgTraditional PCVPCV-VGPlateau airway pressure \[MD (95 % CI)\]−2.58 (−4.74, −0.43)−0.58 (−1.37, 0.20)−1.06 (−2.37, 0.24)−2.78 (−4.21, −1.35)Mean arterial pressure \[MD (95 % CI)\]−2.17 (−7.25, 2.91)1.06 (−1.87, 3.99)0.04 (−3.12, 3.20)0.64 (−3.62, 4.91)

Subgroup analysis on the type of PCV showed decreases in P~plateau~ (MD −2.78; 95 % CI −4.21 to −1.35; I^2^ = 0 %; P \< 0.01) in patients undergoing volume guaranteed pressure-controlled ventilation (PCV-VG) compared to VCV, while traditional PCV showed no significant benefits in P~plateau~ (MD −1.06; 95 % CI −2.37--0.24; I^2^ = 75 %; P = 0.11). With respect to MAP, no significant differences or heterogeneity were found in the subgroup analysis.

Sensitivity analyses of P~plateau~ and PaO~2~/FiO~2~ were also performed. When comparing PCV with VCV, heterogeneity in P~plateau~ could be resolved by excluding the study by Al Shehri et al. ([@CR1]) (MD −0.89; 95 % CI −1.50 to −0.28; I^2^ = 37 %; P \< 0.01). This change had no effect on the final result. Heterogeneity in PaO~2~/FiO~2~ could be resolved by excluding the study by Pardos et al. (Pardos et al. [@CR22]) (MD 74.01; 95 % CI 60.04--87.98; I^2^ = 0 %; P \< 0.01). This change affected the final result and showed PCV benefited PaO~2~/FiO~2~ in comparison with VCV. In the comparison of PV with CV on P~plateau~, heterogeneity and the final result could not be resolved by the exclusion of any study involved in this meta-analysis.

Discussion {#Sec23}
==========

This meta-analysis suggests that PV but not PCV can decrease the incidence of PPCs. Although both PV and PCV can decrease the P~plateau~, subgroup analyses show that PCV-VG (but not traditional PCV) can decrease P~plateau~. Currently available data are insufficient to identify differences between PV and CV or PCV and VCV on the length of hospital stay, PaO~2~/FiO~2~ or MAP.

Our result suggesting that PV with low *V*~T~ can protect surgical patients from PPCs is consistent with recently published studies (Hemmes et al. 2015, Serpa Neto et al. [@CR29], [@CR30]). However, the definition of PV in these studies is ventilation with *V*~T~ ≤ 8 ml/kg, and they also include all surgical patients under general anesthesia (Hemmes et al. 2015). The definition of *V*~T~ and the conclusions from these studies might not be suitable in one-lung ventilation. Our results suggest that PV with *V*~T~ ≤ 6 ml/kg can benefit surgical patients in one-lung ventilation. A high quality retrospective study published recently found that low *V*~T~ does not prevent PPCs, which contradicts our results (Blank et al. [@CR2]). In this retrospective study, fewer than half (47 %) of the patients received PEEP ≥ 5 cmH~2~O (Blank et al. [@CR2]). Atelectasis should be considered in all general anesthetized patients. And it is of great importance to avoiding the occurrence of atelectasis during OLV (Lohser and Slinger [@CR14]). Low *V*~T~ with low PEEP can cause increased amounts of atelectasis (Guldner et al. [@CR6]). Only one study with a sample size of 40 patients used PV with PEEP ≤ 5 cmH~2~O (Lin et al. [@CR12]). In this study performed by Lin et al., PPCs were not included in the outcomes (Lin et al. [@CR12]). To achieve a protective effect on PPCs, PEEP ≥ 5 cmH~2~O may be necessary when PV is used in surgical patients undergoing one-lung ventilation.

P~plateau~ is part of the driving pressure and contributes to ventilator-induced lung injury (Neto et al. [@CR21]). Our results suggest that PV has lower P~plateau~ compared to CV, which might explain the mechanism of decreased PPCs in the PV group. Although PCV can also decrease the P~plateau~ compared to VCV, current data are insufficient to identify any difference between PCV and VCV on PPCs. It should be noted that P~plateau~ in PV is lower than P~plateau~ in PCV on average (Choi et al. [@CR4]; Sungur Ulke et al. [@CR33]). Differences in P~plateau~ may be caused by the differences in *V*~T~. The *V*~T~ in PCV is usually 8 ml/kg or higher, while the *V*~T~ in PV is no more than 6 ml/kg (Michelet et al. [@CR17]; Jung et al. [@CR10]; Pu et al. [@CR25]). PCV-VG is a novel mode of ventilation which has been used in recent years. Although present data suggest that PCV-VG can decrease P~plateau~, more studies are still needed.

A combination of low *V*~T~ and PEEP is generally used in PV. PEEP can cause cardiac compromise, which can be reflected by MAP. Low *V*~T~ may induce hypoxemia. In this meta-analysis, the effects of different ventilation strategies on PaO~2~/FiO~2~ and MAP were compared. Decreasing alveolar oxygen tension could induce HPV and resulted in the redistribution of pulmonary blood flow (Moudgil et al. [@CR20]). HPV had a rapid-onset phase and a delayed phase in response to alveolar hypoxia. The rapid-onset phase reached a plateau at 20--40 min. The delayed phase begins at 40 min and takes more than 2 h to reverse (Lumb and Slinger [@CR15]). PaO~2~/FiO~2~ can be affected by HPV. Because most thoracic surgery can be completed in 2 h, only the results of PaO~2~/FiO~2~ at 20 to 40 min after one-lung ventilation are compared in this meta-analysis. Our results suggest that there is no difference between PV and CV or PCV and VCV on PaO~2~/FiO~2~ and MAP. This result is consistent with clinical studies published previously (Boules and Ghobrial [@CR3]; Qutub et al. [@CR26]).

The studies included in this meta-analysis are all RCTs and the overall quality of their reporting is good. Random sequence generation and allocation concealment are utilized in most studies. This meta-analysis is of high methodological quality assessed by AMSTAR. However, limited by the number of patients, the overall strength of the evidence provided by this meta-analysis is moderate (Additional file [2](#MOESM2){ref-type="media"}).

This meta-analysis has some limitations. First, PPCs include a combination of various lung injuries after surgery. The incidence of atelectasis, volutrauma, barotrauma and ARDS may not be the same with different ventilation strategies. However, this definition of PPCs is thought to be a stronger outcome than a single complication analysis (Hemmes et al. 2015). Second, the surgical procedure is one of the factors that could influence the incidence of PPCs (Licker et al. [@CR11]). Some studies in this meta-analysis did not report the exact surgical procedure and currently available data cannot meet the criteria of subgroup analysis on surgical procedure. However, the differences in surgical procedure can be minimized by randomization. All studies included in this meta-analysis were of randomized design. Third, the length of hospital stay was a combination of ICU days and non-ICU days in many studies included in the meta-analysis. Therefore, the results on the length of hospital stay should be interpreted with caution.

Conclusions {#Sec24}
===========

This meta-analysis suggests that protective ventilation with low *V*~T~ protects surgical patients against PPCs in one-lung ventilation. Further trials are needed to define the role of PCV in preventing PPCs in one-lung ventilation.
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ARDS

:   respiratory distress syndrome

CV

:   conventional ventilation

HPV

:   hypoxic pulmonary vasoconstriction

MAP

:   mean arterial pressure

PaO~2~/FiO~2~

:   oxygen index

PCV

:   pressure-controlled ventilation

PCV-VG

:   volume guaranteed pressure-controlled ventilation

PEEP

:   positive end expiratory pressure

P~plateau~

:   intraoperative plateau airway pressure

PV

:   protective ventilation

VCV

:   volume-controlled ventilation

*V*~T~

:   tidal volume

ZL helped design the study, conduct the study, analyze the data, and write the manuscript. XL helped conduct the study and analyze the data. YH helped conduct the study. JZ helped design the study, conduct the study, and write the manuscript. All authors read and approved the final manuscript.

Acknowledgements {#FPar1}
================

We thank the authors of all the studies included in this meta-analysis.

Competing interests {#FPar2}
===================

The authors declare that they have no competing interests.
